Sankpal et al. demonstrated that p53, which is frequently mutated and inactivated in cancer, binds the EpCAM promoter at p53 candidate binding sites and represses transcription in breast cancer cell lines [52]. This evidence concerns the gene EPCAM and breast carcinoma.